FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutics, namely to a method of treating endometriosis and accompanying adhesive process. Method comprises administering by a patient a medicinal agent containing complex of 3,3-diindolylmethane and β-cyclodextrin, with a certain ratio of components and dosage of 3,3'-diindolylmethane 400–600 mg a day.
EFFECT: invention provides higher bioavailability and improved therapeutic effect of the medicinal agent containing 3,3-diindolylmethane for treating endometriosis, as well as providing effective treatment of accompanying adhesive process.
1 cl, 5 tbl, 6 ex
Authors
Dates
2021-01-13—Published
2020-03-18—Filed